Dashboard
Manage Tickers

BCRXBIOCRYST PHARMACEUTICALS INC

Nasdaq biocryst.com


$ 6.45 $ -0.14 (-2.2 %)    

Thursday, 23-May-2024 13:37:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -5.08 (-1.1 %)
DIA $ 398.57 $ -5.26 (-1.32 %)
SPY $ 530.36 $ -4.82 (-0.9 %)
TLT $ 91.26 $ -0.71 (-0.77 %)
GLD $ 225.37 $ -2.84 (-1.29 %)
$ 6.66
$ 6.60
$ 6.44 x 400
$ 6.46 x 119
$ 6.34 - $ 6.64
$ 4.03 - $ 8.96
4,821,537
na
1.37B
$ 0.90
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-13-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-14-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 03-12-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-08-2017 03-31-2017 10-Q
30 02-27-2017 12-31-2016 10-K
31 11-08-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 03-02-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-bolt-biotherapeutics-shares-are-trading-lower-by-around-34-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Bolt Biotherapeutics Shares Are Tradin...
05/15/2024 17:38:38

biocryst-pharmaceuticals-form-4-filings-shows-cco-charles-k-gayer-bought-30000-shares-at-an-average-price-of-547share-ceo-jon-p-stonehouse-bought-30000-shares-at-an-average-price-of-555share-steven-k-galson-bought-21940-shares-at-an-average-price-of-549share--helen-m-thackray-bought-30000-shares-at-an-average-price-of-586share-anthony-doyle-bought-36300-shares-at-an-average-price-of-557share
BioCryst Pharmaceuticals Form 4 Filings Sh...
05/15/2024 16:26:53

- SEC Filing

nextracker-posts-upbeat-earnings-joins-mondaycom-nu-holdings-and-other-big-stocks-moving-higher-on-wednesday
NEXTracker Posts Upbeat Earnings, Joins mo...
05/15/2024 14:21:59

biocryst-presents-new-real-world-evidence-showing-significant-reductions-in-healthcare-resource-utilization-among-patients-with-hereditary-angioedema-following-initiation-of-orladeyo-berotralstat
BioCryst Presents New Real-world Evidence ...
05/09/2024 11:41:50

jmp-securities-maintains-market-outperform-on-biocryst-pharma-raises-price-target-to-15
JMP Securities Maintains Market Outperform...
05/07/2024 15:29:42

JMP Securities analyst Jonathan Wolleben maintains BioCryst Pharma (NASDAQ:BCRX) with a Market Outperform and raises the pri...

hc-wainwright--co-reiterates-buy-on-biocryst-pharma-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on BioC...
05/07/2024 10:16:41

HC Wainwright & Co. analyst Andrew Fein reiterates BioCryst Pharma (NASDAQ:BCRX) with a Buy and maintains $30 price target.

needham-reiterates-buy-on-biocryst-pharma-maintains-12-price-target
Needham Reiterates Buy on BioCryst Pharma,...
05/07/2024 09:33:05

Needham analyst Serge Belanger reiterates BioCryst Pharma (NASDAQ:BCRX) with a Buy and maintains $12 price target.

biocryst-pharmaceuticals-fantastic-q1-earnings-rides-on-outstanding-orladeyo-performance
BioCryst Pharmaceuticals 'Fantastic' Q1 Ea...
05/06/2024 18:59:35

BioCryst's impressive first-quarter earnings report surpasses estimates. Sales surged to $92.8 million, primarily driven by...

why-perficient-shares-are-trading-higher-by-around-53-here-are-20-stocks-moving-in-mondays-mid-day-session
Why Perficient Shares Are Trading Higher B...
05/06/2024 16:32:34

biocryst-forecasts-2024-orladeyo-revenue-of-390m-400m-the-top-end-of-its-prior-guidance-range-of-380m-400m
Biocryst Forecasts 2024 Orladeyo Revenue O...
05/06/2024 11:05:22

biocryst-pharma-q1-2024-adj-eps-017-beats-021-estimate-sales-92761m-beat-85605m-estimate
BioCryst Pharma Q1 2024 Adj EPS $(0.17) Be...
05/06/2024 11:03:10

biocryst-pharmaceuticals-announced-that-the-brazilian-health-regulatory-agency-has-granted-approval-for-oral-once-daily-orladeyo-berotralstat-for-the-prophylaxis-of-hereditary-angioedema-hae-attacks-in-adults-and-pediatric-patients-12-years
BioCryst Pharmaceuticals Announced That Th...
04/17/2024 08:36:06

needham-reiterates-buy-on-biocryst-pharma-maintains-12-price-target
Needham Reiterates Buy on BioCryst Pharma,...
04/10/2024 11:10:05

Needham analyst Serge Belanger reiterates BioCryst Pharma (NASDAQ:BCRX) with a Buy and maintains $12 price target.

whats-going-on-with-biocryst-stock-after-earnings
What's Going On With BioCryst Stock After ...
02/26/2024 18:30:11

BioCryst reported quarterly losses of 28 cents per share, missing the analyst consensus estimate of losses of 24 cents by 16.67...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
02/26/2024 17:35:26

li-auto-posts-q4-earnings-joins-teva-pharmaceutical-and-other-big-stocks-moving-higher-in-mondays-pre-market-session
Li Auto Posts Q4 Earnings, Joins Teva Phar...
02/26/2024 12:03:47

U.S. stock futures were lower this morning, with the Dow futures trading lower by over 50 points on Monday.

biocryst-forecasts-fiscal-year-2024-orladeyo-net-revenue-of-380m-400m-the-company-expects-operating-profit-in-2024-approaching-positive-eps-and-positive-cash-flow-in-2h-2025
BioCryst Forecasts Fiscal Year 2024 Orlade...
02/26/2024 12:02:59

biocryst-pharma-q4-adjusted-eps-028-misses-024-estimate-sales-9340m-beat-9001m-estimate
BioCryst Pharma Q4 Adjusted EPS $(0.28) Mi...
02/26/2024 12:01:37

BioCryst Pharma (NASDAQ:BCRX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0...

earnings-scheduled-for-february-26-2024
Earnings Scheduled For February 26, 2024
02/26/2024 09:47:53

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on...

a-preview-of-biocryst-pharmas-earnings
A Preview Of BioCryst Pharma's Earnings
02/23/2024 19:01:35

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION